K152794

Substantially Equivalent

Cytosponge Cell Collection Device

Applicant: Covidien, LLC
Product code: EOX
Advisory panel: Ear, Nose, Throat
Date received: 2015-09-28
Decision date: 2016-04-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mansfield, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.